Deep dive into drug substance HCP patterns for comprehensive safety assessment in recombinant mAb formats
Daniel M. Waldera‐Lupa,
Anne Gehrke‐Oltmanns,
Alireza Dehghani,
Melissa Morgenroth,
Antje‐Alke Betz,
Heiner Falkenberg,
Thomas Flad,
Ulli Backofen,
Thomas Waerner
Wiley ·
2026-07-08
· DOI 10.1002/btpr.88540
⬢ Cited by: 0Crossref
The publisher did not provide an abstract — full text is available via the link below.
Daniel M. Waldera‐Lupa, Anne Gehrke‐Oltmanns, Alireza Dehghani, Melissa Morgenroth, Antje‐Alke Betz, Heiner Falkenberg et al. Deep dive into drug substance HCP patterns for comprehensive safety assessment in recombinant mAb formats. // Biotechnology Progress. – 2026. – DOI: 10.1002/btpr.88540. – URL: https://aiche.onlinelibrary.wiley.com/doi/10.1002/btpr.88540?af=R
Daniel M. Waldera‐Lupa, Anne Gehrke‐Oltmanns, Alireza Dehghani, Melissa Morgenroth, Antje‐Alke Betz, Heiner Falkenberg, Thomas Flad, Ulli Backofen, & Thomas Waerner (2026). Deep dive into drug substance HCP patterns for comprehensive safety assessment in recombinant mAb formats. Biotechnology Progress. https://doi.org/10.1002/btpr.88540
Daniel M. Waldera‐Lupa, et al. “Deep dive into drug substance HCP patterns for comprehensive safety assessment in recombinant mAb formats.” Biotechnology Progress, 2026. doi:10.1002/btpr.88540.
@article{WalderaLupa2026,
title = {Deep dive into drug substance HCP patterns for comprehensive safety assessment in recombinant mAb formats},
author = {Waldera‐Lupa, Daniel M. and Gehrke‐Oltmanns, Anne and Dehghani, Alireza and Morgenroth, Melissa and Betz, Antje‐Alke and Falkenberg, Heiner and Flad, Thomas and Backofen, Ulli and Waerner, Thomas},
journal = {Biotechnology Progress},
year = {2026},
doi = {10.1002/btpr.88540},
url = {https://aiche.onlinelibrary.wiley.com/doi/10.1002/btpr.88540?af=R}
}